DERMATOMYOSITIS (DM)
Clinical trials for DERMATOMYOSITIS (DM) explained in plain language.
Never miss a new study
Get alerted when new DERMATOMYOSITIS (DM) trials appear
Sign up with your email to follow new studies for DERMATOMYOSITIS (DM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug RAY121 shows promise for controlling rare immune disorders
Disease control ENROLLING_BY_INVITATIONThis study tests a drug called RAY121 in people with certain immune system diseases, such as antiphospholipid syndrome and immune thrombocytopenia. The goal is to see if long-term use can safely control these conditions. Participants must have already responded to RAY121 in a pre…
Matched conditions: DERMATOMYOSITIS (DM)
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
AI and PET scans join forces to spot lung trouble in rare muscle disease
Knowledge-focused OngoingThis study aims to create a new way to diagnose interstitial lung disease (ILD) in people with dermatomyositis, a rare muscle condition. Researchers will use special PET/CT scans and machine learning to find patterns that predict ILD. The study involves 200 adults and compares th…
Matched conditions: DERMATOMYOSITIS (DM)
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC